1.
Antimicrob Agents Chemother
; 68(5): e0159123, 2024 May 02.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38578080
RESUMEN
We recruited 48 neonates (50 vancomycin treatment episodes) in a prospective study to validate a model-informed precision dosing (MIPD) software. The initial vancomycin dose was based on a population pharmacokinetic model and adjusted every 36-48 h. Compared with a historical control group of 53 neonates (65 episodes), the achievement of a target trough concentration of 10-15 mg/L improved from 37% in the study to 62% in the MIPD group (P = 0.01), with no difference in side effects.